Maintain LMT at 2% weight; patient staged entry at $588-595 rather than adding at $607
Structural bullish thesis (PAC-3 $58.62B backlog, Q2 EPS $7.94, 12.4% operating margin) is too durable to underweight, but current entry at $607 is at upper end of fair value ($590-610). MACD histogram contraction (~60%), persistent RSI 63-70 range, and incomplete SMA stack (50 SMA $538.78 below 200 SMA $544.63) constitute genuine technical warnings. Be patient, wait for $588 or better, and let technical setup complete before adding exposure. Position sizing at 2% (lower end) reflects that LMT is one of the more expensive defense primes at top of TTM P/E 22.4x range with crowded institutional bullishness.
| Position | Action |
|---|---|
| Current portfolio weight | Maintain at 2% (lower end of 2-3% range) |
| Price at $607 (current) | Do NOT add; price at upper end of fair value ($590-610) |
| First add trigger: price $588-595 with RSI cooling to 55-60 | Add to position incrementally |
| Second add trigger: confirmed 200 SMA retest with bullish price action | Add to position on higher-quality setup |
| Third add trigger: Q3 2026 earnings beat-and-raise with PAC-3 flow-through | Add on fundamental catalyst validation |
| Hard invalidation: 200 SMA close below $544 | Exit or reduce position |
Lockheed Martin represents a multi-year secular defense spending opportunity anchored by the $58.62B PAC-3 MSE mega-contract, with confirmed technical trend reversal, accelerating fundamentals (TTM revenue at all-time high of $77.0B, Q2 2026 EPS of $7.94), deleveraging balance sheet, and 21% forward EPS growth—positioned as the defense supercycle leader.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $588.33 | bullish |
| 50 SMA | $538.78 | neutral |
| 200 SMA | $544.63 | neutral |
| MACD | 19.14 | bullish |
| MACD Signal | 16.47 | bullish |
| MACD Histogram | 2.67 | bearish |
| RSI | 69.58 | bullish |
| ATR | $15.74 | neutral |
| Price Close | $606.72 | bullish |
Support: 588.33 · 544.63 · 538.78 | Resistance: 610 · 620 · 644.94
LMT exhibits a classic bullish stack with price ($606.72) above all key moving averages (10 EMA $588.33, 200 SMA $544.63, 50 SMA $538.78), a MACD bullish crossover in place since July 23, and RSI oscillating near overbought without bearish divergence. The primary concern is MACD histogram contraction from 6.58 (Jul 30) to 2.67 — a ~60% momentum decay signaling potential late-stage rally characteristics. ATR has expanded 31% from pre-rally baseline ($11.98 to $15.74), implying daily noise bands of ~$15–$16. The 50 SMA has not yet re-crossed above the 200 SMA, so a fresh "golden cross" confirmation remains outstanding. Tactical approach is to hold existing longs with disciplined stops (10 EMA or 2× ATR) and await either a pullback to ~$588–$595 or a confirmed breakout above the $610–$620 resistance zone before adding positions.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Technical reversal is confirmed with price reclaiming all major moving averages and MACD bullish crossover intact
· concedes: Fed no-cuts regime is a mild multiple headwind for long-duration cash flows; PAC-3 award is undefinitized with definitization milestones pending (weeks-to-months schedule risk); MACD histogram contracting from 6.58 to 2.67 (momentum digestion); Price 3.1% above 10 EMA represents minor overextension (~$18); F-35 program margins may stay pressured despite stabilization trajectory
LMT is a fully priced, momentum-chased name at the top of its historical P/E range (TTM 22.4x), with the current rally being a vertical move that needs digestion rather than a confirmed reversal, making the risk/reward at $607 asymmetric to the downside.
· concedes: The fundamentals are real, the backlog is real, and the dividend is real; Not shorting LMT—the underlying business has genuine value; The bull's recommended stop at $588 is also my recommended entry—I would buy there; Q2 2026 EPS of $7.94 does represent a sequential improvement; Operating margin recovery to 12% is real, just incomplete
→ vs conservative: Barbell position sizing with RTX and NOC underweights LMT; near-zero beta (0.11) makes conservative scaling inappropriate for this government-backed cash flow machine
→ vs conservative: Waiting for pullback to 50 SMA misses multi-year supercycle entry; technical support is $544 (10% drop) with no signal suggesting imminent pullback
→ vs conservative: Covered call strategy can monetize limited near-term upside (9.4% options cap) rather than reducing position exposure
→ vs neutral: Incomplete bullish stack argument based on 50 SMA below 200 SMA uses lagging indicators that miss the actual trend signal
→ vs neutral: Trading on MACD histogram contraction during confirmed uptrend with intact crossover and higher highs creates whipsaw risk
→ vs neutral: P/E comparison to RTX and NOC ignores LMT's most defensible backlog position in defense sector
Market Cap
$140.0B
P/E (TTM)
22.36x
Forward P/E
18.54x
PEG Ratio
1.25
Price/Book
15.92x
EPS (TTM)
$27.14
Forward EPS
$32.72
Dividend Yield
2.29%
Beta
0.11
52-Week Range
$431.42 – $692.00
50-Day MA
$536.98
200-Day MA
$548.33
Book Value/Share
$38.12
Revenue 2022
$65,984M
Revenue 2023
$67,571M
Revenue 2024
$71,043M
Revenue 2025
$75,048M
Revenue TTM
$77,014M
Net Income 2022
$5,732M
Net Income 2023
$6,920M
Net Income 2024
$5,336M
Net Income 2025
$5,017M
Net Income TTM
$6,287M
Diluted EPS 2022
$21.66
Diluted EPS 2023
$27.55
Diluted EPS 2024
$22.31
Diluted EPS 2025
$21.49
Diluted EPS TTM
$27.14
Q2 2026 Revenue
$20.06B
Q2 2026 Net Income
$1.84B
Q2 2026 EPS
$7.94
Cash & Equivalents
$3.79B
Receivables
$19.39B
Inventory
$4.41B
Current Assets
$28.40B
Goodwill & Intangibles
$13.09B
Net PP&E
$11.39B
Total Assets
$62.45B
Accounts Payable
$4.92B
Current Deferred Revenue
$12.15B
Current Liabilities
$23.81B
Long-Term Debt
$20.54B
Pension Obligations
$3.93B
Total Liabilities
$53.68B
Stockholders' Equity
$8.77B
Current Ratio
1.19x
Net Debt
$16.7B
Working Capital
$4.6B
Debt-to-Equity
~2.34x
Profit Margin
8.16%
Operating Margin
11.96%
Return on Equity
89.2%
Return on Assets
8.64%
Free Cash Flow TTM
$5.56B
Q2 2026 FCF
$2.92B
Annual CapEx
~$1.6B
Annual Dividends
~$3.2B
Annual Buybacks
~$2.25B
Backlog
~$176B+
Strengths
Concerns
Lockheed Martin is the world's largest defense contractor with four business segments (Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, Space) serving primarily the U.S. government. The company generated TTM revenue of $77.0B with net income of $6.29B and EPS of $27.14, recovering strongly from a 2024 profit trough driven by F-35 program losses and supply chain inflation. The balance sheet shows $62.45B in total assets, $20.54B in long-term debt, and stockholders' equity that grew 65% YoY to $8.77B, while the company maintains a $176B+ backlog for multi-year revenue visibility. With forward EPS of $32.72 implying ~21% growth, a 2.29% dividend yield, and an extremely low 0.11 beta, LMT trades at 22.4x P/E (TTM) and 18.5x forward P/E, presenting a high-quality defensive holding with steady capital returns but limited near-term upside at current valuations.
Macro: Fed rate-cut probability: 0% cuts in 2026 priced at 86% (Polymarket, down 2pp w/w). US recession by end-2026: 8% probability (down 1pp w/w). UK recession: 20%; Japan recession: 28%. Sticky inflation print keeping Fed sidelined (WSJ). Soft-landing consensus intact — neutral-to-modestly-negative for defense prime multiples (long-duration cash flows), but government-secured revenue limits cash-flow impact.